Prospective evaluation of long-term safety of dual-release hydrocortisone replacement administered once daily in patients with adrenal insufficiency

OBJECTIVE: The objective was to assess the long-term safety profile of dual-release hydrocortisone (DR-HC) in patients with adrenal insufficiency (AI). DESIGN: Randomised, open-label, crossover trial of DR-HC or thrice-daily hydrocortisone for 3 months each (stage 1) followed by two consecutive, pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Nilsson, A G, Marelli, C, Fitts, D, Bergthorsdottir, R, Burman, P, Dahlqvist, P, Ekman, B, Edén Engström, B, Olsson, T, Ragnarsson, O, Ryberg, M, Wahlberg, J, Lennernäs, H, Skrtic, S, Johannsson, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106399/
https://www.ncbi.nlm.nih.gov/pubmed/24944332
http://dx.doi.org/10.1530/EJE-14-0327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4106399/
https://www.ncbi.nlm.nih.gov/pubmed/24944332
http://dx.doi.org/10.1530/EJE-14-0327

Ejemplares similares